(S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide, 95.0%, 50g

ethyl 2-(6-methoxy-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)-2-oxoacetate, 95.0%, 10g

4-Pyridinecarboxamide, 2-(cyclobutylamino)-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-, 98%, 5mg

Methyl 1-phenylcyclopropane-1-carboxylate, 97%, 5g

1-(3-Fluoro-4-methoxyphenyl)ethanol, 97.0%, 100mg

5-(2-((3-(tert-Butylamino)-2-hydroxypropyl)thio)thiazol-4-yl)thiophene-2-carboxamide, 95.0%, 5mg

1-Nonadecanol>98.0%(GC)5g

5-{[(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-carbamoyl-2,6-dimethylphenyl)-N-[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]propanamido]methyl}-2-methoxybenzoic acid, 97%, 250mg

1,3-Bis(2-hydroxyhexafluoroisopropyl)benzene, 97.0%, 10g

Cryogenic box ROTILABO® 100 slots, blue, 1 Piece

3-Oxa-7-azabicyclo[3.3.1]nonane, 98%, 500mg

2,2,3,3,4,4,5,5,6,6,7,7-Dodecafluoroheptyl Methacrylate (stabilized with TBC)>97.0%(GC)25g

2-Aminoheptanedioic acid, 95.0%, 25g